Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Arthur J. Gallagher & Co
AJG
$65B
| $3.17M | 0.01% |
77,400
-432,700
| -85% | -$18.6M |
|
|
RC
1802
Ready Capital
RC
$294M
| $3.17M | 0.01% |
210,090
+80,674
| +62% | +$1.18M |
|
|
SVC
1803
Service Properties Trust
SVC
$1.06B
| $3.16M | 0.01% |
24,200
-49,351
| -67% | -$6.63M |
|
1804
GATX Corp
GATX
$6.33B
| $3.16M | 0.01% |
+74,200
| New | +$3.35M |
|
|
ABCW
1805
DELISTED
ANCHOR BANCORP WISCONSIN INC COMMON STOCK
ABCW
| $3.15M | 0.01% |
72,500
-53,200
| -42% | -$2.26M |
|
|
GLUU
1806
DELISTED
Glu Mobile Inc.
GLUU
| $3.15M | 0.01% |
1,297,413
+841,013
| +184% | +$2.89M |
|
|
PZN
1807
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $3.15M | 0.01% |
366,200
+40,000
| +12% | +$368K |
|
1808
Vanda Pharmaceuticals
VNDA
$304M
| $3.14M | 0.01% |
+337,390
| New | +$3.37M |
|
1809
CEVA Inc
CEVA
$855M
| $3.14M | 0.01% |
134,300
+71,000
| +112% | +$1.69M |
|
1810
TTM Technologies
TTMI
$14.6B
| $3.13M | 0.01% |
481,230
-478,999
| -50% | -$3.44M |
|
|
CTCM
1811
DELISTED
CTC MEDIA INC COM STK
CTCM
| $3.13M | 0.01% |
1,692,200
+847,100
| +100% | +$1.52M |
|
1812
Vail Resorts
MTN
$5.18B
| $3.12M | 0.01% |
24,400
-212,000
| -90% | -$24.9M |
|
1813
IES Holdings
IESC
$14.9B
| $3.12M | 0.01% |
281,532
+16,100
| +6% | +$130K |
|
1814
Healthcare Services Group
HCSG
$1.45B
| $3.12M | 0.01% |
+89,364
| New | +$3.25M |
|
1815
Exelixis
EXEL
$12.5B
| $3.11M | 0.01% |
+551,350
| New | +$3.09M |
|
|
LDR
1816
DELISTED
Landauer Inc
LDR
| $3.11M | 0.01% |
94,400
+32,100
| +52% | +$1.22M |
|
1817
Tompkins Financial
TMP
$1.45B
| $3.1M | 0.01% |
55,200
+13,900
| +34% | +$801K |
|
|
MJN
1818
DELISTED
Mead Johnson Nutrition Company
MJN
| $3.1M | 0.01% |
39,200
-2,924,100
| -99% | -$230M |
|
1819
Harmonic Inc
HLIT
$1.42B
| $3.09M | 0.01% |
759,700
+238,000
| +46% | +$1.27M |
|
|
MANT
1820
DELISTED
Mantech International Corp
MANT
| $3.09M | 0.01% |
102,119
+54,719
| +115% | +$1.63M |
|
1821
Insulet
PODD
$10.2B
| $3.08M | 0.01% |
+81,600
| New | +$2.75M |
|
|
OMN
1822
DELISTED
OMNOVA Solutions Inc.
OMN
| $3.07M | 0.01% |
500,875
+54,600
| +12% | +$370K |
|
1823
Virtu Financial
VIRT
$5.05B
| $3.06M | 0.01% |
+135,200
| New | +$3.11M |
|
1824
Old Second Bancorp
OSBC
$1.31B
| $3.05M | 0.01% |
389,600
+27,700
| +8% | +$200K |
|
|
USAK
1825
DELISTED
USA Truck Inc
USAK
| $3.05M | 0.01% |
174,900
+4,700
| +3% | +$88.2K |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.